|
| ID |
DDInter518 |
| Drug Type |
small molecule |
| Molecular Formula |
C12H16F3N |
| Molecular Weight |
231.261
|
| Description |
Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. For a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn.
|
| ATC Classification |
A08AA04
|
| IUPAC Name |
Ethyl[(2S)-1-[3-(Trifluoromethyl)Phenyl]Propan-2-Yl]Amine |
| InChI |
Inchi=1S/C12H16F3N/C1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/H4-6,8-9,16H,3,7H2,1-2H3/T9-/M0/S1 |
| InChI Key |
DBGIVFWFUFKIQN-VIFPVBQESA-N |
| Canonical SMILES |
CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F |
| Useful Links |
DrugBank
ChEMBL
PubChem
|